The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Management of venous port systems in oncology: a review of current evidence
Open accessAbstract
Background Over the last decades, many changes have occurred in oncology with new chemotherapy combinations and more complex application schemes becoming available. Central venous catheters and implantable venous port systems have become widely used and have facilitated the problem of vascular access. However, important complications are associated with permanent central venous catheters.Material and methods This review summarizes evidence on venous port system use published in Medline up to February 2007. Moreover, recent guidelines for the prevention and management of catheter-related infections issued by the Infectious Diseases Society of America, the American College of Critical Care Medicine, the Society for Healthcare Epidemiology of America, the Center for Disease Control and Prevention, Atlanta, and the Infectious Diseases Working Party of the German Society of Hematology and Oncology are included.Results Sterile precautions are essential when implanting and accessing port systems. Infections must be treated with adequate antimicrobial therapy. Catheter-related thromboembolic complications were found at a rate of 12-64% in retrospective studies. Five current clinical trials investigated the effect of prophylactic anticoagulation with either low molecular weight heparin or warfarin in cancer patients with central venous devices. On the basis of these results, routine anticoagulation cannot be recommended.Conclusions This article reviews the current literature on long-term complications of venous port systems, focusing on infection and thrombosis. In addition, it summarizes the evidence regarding routine maintenance of port systems in follow-up care.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The access required for intravenous infusions, the standard administration route for biologic drugs in oncology, involves invasive procedures that can be inconvenient and painful and a drain on the time and resources of patients, healthcare professionals (HCPs), and the healthcare system in general [2–4].”
From Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities (2018) · cites this paper as [3]
Citations
Cites
Guidelines for the Prevention of Intravascular Catheter-related Infections
O’Grady, N. P., Alexander, M., Burns, L. A., Dellinger, E. P., Garland, J. L., Heard, S. O., Lipsett, P. A., Masur, H., Mermel, L. A., Pearson, M. L., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir257 · Cited by 4,727
Guidelines for the management of intravascular catheter-related infections
Mermel, L. A., Farr, B. M., Sherertz, R. J., Raad, I. I., O'Grady, N., Harris, J. S., & Craven, D. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320001 · Cited by 1,449
Nosocomial Infections in Combined Medical-Surgical Intensive Care Units in the United States
Richards, M. J., Edwards, J. R., Culver, D. H., Gaynes, R. P., & System, N. N. I. S. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501795 · Cited by 1,028
Very Low Doses of Warfarin Can Prevent Thrombosis in Central Venous Catheters
Bern, M. M., Lokich, J. J., Wallach, S. R., Bothe, A., Benotti, P. N., Arkin, C. F., Greco, F. A., Huberman, M., & Moore, C. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-3-112-6-423 · Cited by 787
Complications and Failures of Subclavian-Vein Catheterization
Mansfield, P. F., Hohn, D. C., Fornage, B. D., Gregurich, M. A., & Ota, D. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412293312602 · Cited by 709
A modified right atrial catheter for access to the venous system in marrow transplant recipients.
Hickman, R. O., Buckner, C. D., Clift, R. A., Sanders, J. E., STEWART, P. S., & Thomas, E. D. (1979) · PubMed · Cited by 647
Complications and Failures of Subclavian-Vein Catheterization
Mansfield, P. F., Höhn, D., Fornage, B. D., Gregurich, M. A., & Ota, D. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506083322313 · Cited by 626
Venous Thromboembolism Associated With Long-Term Use of Central Venous Catheters in Cancer Patients
Verso, M., & Agnelli, G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.008 · Cited by 611
A silicone rubber atrial catheter for prolonged parenteral alimentation.
Broviac, J. W., Cole, J. J., & Scribner, B. H. (1973) · PubMed · Cited by 550
Niederhuber, J. E., Ensminger, W. D., Gyves, J. W., Liepman, M., Doan, K., & Cozzi, E. (1982) · PubMed · Cited by 513
Cited by
Sorted by citations
Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
Bittner, B., Richter, W., & Schmidt, J. (2018) · BioDrugs · doi:10.1007/s40259-018-0295-0 · Cited by 447
Vascular Access in Oncology Patients
Gallieni, M. A., Pittiruti, M., & Biffi, R. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2008.0015 · Cited by 285
Biffi, R., Orsi, F., Pozzi, S., Pace, U., Bonomo, G., Monfardini, L., Vigna, P. D., Rotmensz, N., Radice, D., Zampino, M. G., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn701 · Cited by 237
Central venous access in oncology: ESMO Clinical Practice Guidelines
Sousa, B., Furlanetto, J., Hutka, M., Gouveia, P. F., Wuerstlein, R., Mariz, J., Pinto, D., & Cardoso, F. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv296 · Cited by 198
Lebeaux, D., Fernández‐Hidalgo, N., Chauhan, A., Lee, S. J., Ghigo, J., Almirante, B., & Beloin, C. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70266-4 · Cited by 193
Metadata
- Authors
- Vescia, S., Baumgärtner, A. K., Jacobs, V. R., Kiechle-Bahat, M., Rody, A., Loibl, S., & Harbeck, N.
- Affiliations
- German Breast Group (DE)
- TUM Klinikum (DE)
- University Hospital Frankfurt (DE)
- Corresponding author
- Baumgärtner, A.K.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2008-01
- Volume
- 19
- Issue
- 1
- Pages
- 9-15
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2150240326
- Cited by
- 264
- References
- 56
- Citations by year
- 2026: 10 · 2025: 10 · 2024: 11 · 2023: 11 · 2022: 13 · 2021: 13 · 2020: 13 · 2019: 7 · 2018: 21 · 2017: 14 · 2016: 17 · 2015: 8 · 2014: 21 · 2013: 12 · 2012: 20
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Annals of Oncology (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Central Venous Catheters and Hemodialysis
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Keywords
- central venous catheters, catheter-related infection, catheter-related thrombosis, thromboprophylaxis, low molecular weight heparin, warfarin, port maintenance, infection prevention guidelines
- MeSH terms
- Anticoagulants, Antineoplastic Agents, Catheterization, Central Venous, Catheters, Indwelling, Clinical Trials as Topic, Equipment Contamination, Humans, Neoplasms, Thromboembolism, Fungemia, Bacteremia, Infection Control, Antibiotic Prophylaxis, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
